Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
Clinical trial NCT02039505 · COMPLETED
Trial details
- NCT number
- NCT02039505
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-04
- Primary completion
- 2018-02-27
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.